Viyash Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Viyash Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Viyash Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SEQUENT total liabilities for a breakdown of total debt and financial obligations.

Viyash Scientific Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Viyash Scientific Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pepper Money Ltd AU:PPM	-1.010x
Kunming Yunnei Power Co Ltd SHE:000903	-0.122x
Nanjing Well Pharmaceutical Co Ltd SHG:603351	0.039x
Shenzhen Jinxinnong Feed Co Ltd SHE:002548	-0.071x
Pagerduty Inc NYSE:PD	0.094x
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	0.000x
Sinon Corp TW:1712	0.127x
Jing Jin Electric Technologies Co Ltd SHG:688280	0.329x

Annual Cash Flow Conversion Efficiency for Viyash Scientific Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Viyash Scientific Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Viyash Scientific Limited (SEQUENT) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs7.70 Billion ≈ $83.31 Million	Rs833.60 Million ≈ $9.02 Million	0.108x	+152.16%
2024-03-31	Rs7.13 Billion ≈ $77.10 Million	Rs305.95 Million ≈ $3.31 Million	0.043x	+91.28%
2023-03-31	Rs7.49 Billion ≈ $81.02 Million	Rs168.08 Million ≈ $1.82 Million	0.022x	-45.73%
2022-03-31	Rs7.40 Billion ≈ $80.04 Million	Rs305.95 Million ≈ $3.31 Million	0.041x	-72.03%
2021-03-31	Rs7.76 Billion ≈ $83.96 Million	Rs1.15 Billion ≈ $12.41 Million	0.148x	-6.20%
2020-03-31	Rs7.32 Billion ≈ $79.15 Million	Rs1.15 Billion ≈ $12.47 Million	0.158x	+1.45%
2019-03-31	Rs7.47 Billion ≈ $80.78 Million	Rs1.16 Billion ≈ $12.55 Million	0.155x	+135.05%
2018-03-31	Rs6.85 Billion ≈ $74.03 Million	Rs452.39 Million ≈ $4.89 Million	0.066x	+1013.61%
2017-03-31	Rs9.94 Billion ≈ $107.50 Million	Rs-71.90 Million ≈ $-777.57K	-0.007x	-12597.48%
2016-03-31	Rs9.48 Billion ≈ $102.51 Million	Rs-540.00K ≈ $-5.84K	0.000x	+99.94%
2015-03-31	Rs2.38 Billion ≈ $25.76 Million	Rs-235.49 Million ≈ $-2.55 Million	-0.099x	+86.47%
2014-03-31	Rs613.06 Million ≈ $6.63 Million	Rs-447.85 Million ≈ $-4.84 Million	-0.731x	-1803.87%
2013-03-31	Rs995.83 Million ≈ $10.77 Million	Rs-38.21 Million ≈ $-413.23K	-0.038x	-116.25%
2012-03-31	Rs1.28 Billion ≈ $13.84 Million	Rs302.36 Million ≈ $3.27 Million	0.236x	-37.08%
2011-03-31	Rs1.35 Billion ≈ $14.60 Million	Rs506.60 Million ≈ $5.48 Million	0.375x	+148.36%
2010-03-31	Rs1.12 Billion ≈ $12.09 Million	Rs168.95 Million ≈ $1.83 Million	0.151x	+223.00%
2009-03-31	Rs405.20 Million ≈ $4.38 Million	Rs-49.79 Million ≈ $-538.46K	-0.123x	-14561.60%
2008-03-31	Rs573.71 Million ≈ $6.20 Million	Rs487.47K ≈ $5.27K	0.001x	-99.26%
2007-03-31	Rs349.24 Million ≈ $3.78 Million	Rs40.21 Million ≈ $434.91K	0.115x	-68.51%
2006-03-31	Rs198.08 Million ≈ $2.14 Million	Rs72.43 Million ≈ $783.26K	0.366x	--

About Viyash Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic

Market Cap

$529.07 Million

Rs48.92 Billion INR

Market Cap Rank

#12345 Global

#576 in India

Share Price

Rs193.72

Change (1 day)

-3.70%

52-Week Range

Rs168.04 - Rs252.00

All Time High

Rs322.89